The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
…, P Werner, M Knoflach, M Furtner, J Willeit… - Expert review of …, 2006 - Taylor & Francis
Owing to the common coincidence of osteoporosis and vascular disease, pathophysiological
links between both disorders have long been sought. The osteoprotegerin (OPG)/receptor …
links between both disorders have long been sought. The osteoprotegerin (OPG)/receptor …
[HTML][HTML] Toll-like receptor 4 polymorphisms and atherogenesis
…, F Oberhollenzer, E Bonora, J Willeit… - … England Journal of …, 2002 - Mass Medical Soc
Background The ability to mount a prominent inflammatory response to bacterial pathogens
confers an advantage in innate immune defense but may signal an increased risk of …
confers an advantage in innate immune defense but may signal an increased risk of …
Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration
…, E Mathiesen, M Plichart, J Kauhanen, J Willeit… - Diabetes …, 2015 - Am Diabetes Assoc
OBJECTIVE Carotid intima-media thickness (CIMT) is a marker of subclinical organ damage
and predicts cardiovascular disease (CVD) events in the general population. It has also …
and predicts cardiovascular disease (CVD) events in the general population. It has also …
Telomere length and risk of incident cancer and cancer mortality
P Willeit, J Willeit, A Mayr, S Weger, F Oberhollenzer… - Jama, 2010 - jamanetwork.com
… Willeit was supported by a scholarship from the Dr Johannes and Hertha Tuba Foundation.
Dr Kronenberg was supported by a grant from the Competence Centers for Excellent …
Dr Kronenberg was supported by a grant from the Competence Centers for Excellent …
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes
…, F Oberhollenzer, E Bonora, A Shah, J Willeit… - Circulation …, 2010 - Am Heart Assoc
Rationale: MicroRNAs (miRNAs) have been implicated in the epigenetic regulation of key
metabolic, inflammatory, and antiangiogenic pathways in type 2 diabetes (DM) and may …
metabolic, inflammatory, and antiangiogenic pathways in type 2 diabetes (DM) and may …
Cardioprotection and lifespan extension by the natural polyamine spermidine
Aging is associated with an increased risk of cardiovascular disease and death. Here we
show that oral supplementation of the natural polyamine spermidine extends the lifespan of …
show that oral supplementation of the natural polyamine spermidine extends the lifespan of …
Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community
…, P Willeit, S Kiechl, H Stockner, J Willeit… - Movement …, 2016 - Wiley Online Library
Background Recently, the International Parkinson and Movement Disorder Society has
defined research criteria for prodromal Parkinson's disease (PD), but to date their predictive …
defined research criteria for prodromal Parkinson's disease (PD), but to date their predictive …
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
E Bonora, S Kiechl, J Willeit, F Oberhollenzer… - Diabetes, 1998 - Am Diabetes Assoc
The prevalence of insulin resistance in the most common metabolic disorders is still an
undefined issue. We assessed the prevalence rates of insulin resistance in subjects with …
undefined issue. We assessed the prevalence rates of insulin resistance in subjects with …
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study
Background—Chronic infections have been implicated in the pathogenesis of atherosclerosis,
yet from an epidemiological perspective, this concept remains controversial. Methods and …
yet from an epidemiological perspective, this concept remains controversial. Methods and …
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
…, A Mayr, P Santer, J Smolen, W Poewe, J Willeit - Circulation, 2004 - Am Heart Assoc
Background— Osteoprotegerin is a novel member of the tumor necrosis factor receptor
superfamily and a soluble decoy receptor of the receptor activator of nuclear factor-κB ligand. …
superfamily and a soluble decoy receptor of the receptor activator of nuclear factor-κB ligand. …